This Ask the Doctor About Lymphoma program will be a virtual program to deliver live patient education programming during the coronavirus (COVID-19) outbreak. This program will still provide access to local lymphoma experts, and you can tune in over the phone or online. Please continue to check this page for updates.

Virtual Ask the Doctor About Lymphoma

Thursday, March 4, 2021
5:00 PM – 7:00 PM CT (6:00 PM ET)

VIRTUAL PROGRAM – This is a virtual event, accessible online and over the phone. Access instructions will be provided after registration and prior to program.  Confirmation emails will show sender as Beacon 360.


Siddhartha Ganguly, MD, FACP
A. Drue Jennings Professor of Medical Oncology
Deputy Director, Hematological Malignancies and Cellular Therapeutics
Associate Director, Blood and Marrow Transplantation
Director, Lymphoma and Myeloma Program
University of Kansas Health System
Kansas City, Kansas

Program Overview

  • Lymphoma Overview
  • Immune System Overview
  • COVID19 and Lymphoma
  • Question and Answer Session

To Register

VIRTUAL PROGRAM – This is a virtual Zoom event, accessible online and over the phone. Access instructions will be emailed after registration. If you are new to Zoom, learn more here: How-Do-I-Join-or-Test-My-Computer-Audio

Call: 1-800-500-9976

This program is offered free-of-charge to members of the lymphoma community; however, pre-registration is required.

Disclaimer: The Lymphoma Research Foundation (LRF) is a national nonprofit organization based in the United States with educational programs and resources are intended for a US-based audience. These program and resources address available lymphoma treatments in the United States. and information on drug approvals by the US Food and Drug Administration.

For individuals outside of the US, LRF recommends the Lymphoma Coalition at The Lymphoma Coalition is a global network of worldwide nonprofit/NGO lymphoma patient organizations with information appropriate for non US-based audiences.

Program Supporters

This program is supported through unrestricted educational grants from:

Seagen Logo